|
![]() |
|||
|
||||
OverviewNew Mechanisms in Glucose Control presents a clear overview of the new drugs and treatment therapies that have been developed in recent years to help improve glycaemic management for the diabetic patient, namely the incretin mimetics (GLP-1 agonists) and DPP-4 inhibitors. It also considers other drug classes currently in development and undergoing clinical trials including the SGLT2 inhibitors and other pipeline products. In addition to pharma cotherapeutic agents, the role of bariatric as a management tool for diabetes is covered as well as consideration of the organisation of diabetes care with a community focus.This indispensable pocketbook details the newer treatments and offers a comparison with more traditional agents including sulphonyureas, glitazones and insulin. The pros and cons of traditional therapies are discussed as well as the epidemiology and pathogenesis of type 2 diabetes, helping to give the reader a better understanding of the disease area and its management. New Mechanisms in Glucose Control is essential reading for health professionals working in primary or secondary care and involved in treating diabetic patients. Full Product DetailsAuthor: Anthony H Barnett, M.D. (Professor of Medicine, University of Birmingham, Consultant Physician and Head of Diabetes Services, Birmingham Heartlands and Solihull NHS Trust (Teaching), Birmingham, UK) , Jenny Grice (Medical Writer, Bieuzy les Eaux, France)Publisher: Bmj Publishing Group Imprint: Bmj Publishing Group ISBN: 9781299468832ISBN 10: 1299468837 Pages: 74 Publication Date: 01 January 2013 Audience: General/trade , General Format: Electronic book text Publisher's Status: Active Availability: Available To Order ![]() We have confirmation that this item is in stock with the supplier. It will be ordered in for you and dispatched immediately. Table of ContentsReviewsAuthor InformationTab Content 6Author Website:Countries AvailableAll regions |